These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 15816086)
1. Vitamin E from select plant seeds could inhibit lung and prostate cancer growth. Health News; 2005 Apr; 11(4):7. PubMed ID: 15816086 [No Abstract] [Full Text] [Related]
2. Vitamin E and prostate cancer: where do we stand? Harv Mens Health Watch; 2006 Jan; 10(6):5-7. PubMed ID: 18828212 [No Abstract] [Full Text] [Related]
3. [SETTI-Study and antioxidants--more questions than answers]. Huttunen J; Kontula K Duodecim; 1994; 110(12):1115-8. PubMed ID: 7497914 [No Abstract] [Full Text] [Related]
4. RE: Lessons from the selenium and vitamin E cancer prevention trial (SELECT). Schrauzer GN Crit Rev Biotechnol; 2009; 29(2):81. PubMed ID: 19514891 [No Abstract] [Full Text] [Related]
5. The modulation of prostate cancer risk with alpha-tocopherol: a pilot randomized, controlled clinical trial. Hernáandez J; Syed S; Weiss G; Fernandes G; von Merveldt D; Troyer DA; Basler JW; Thompson IM J Urol; 2005 Aug; 174(2):519-22. PubMed ID: 16006884 [TBL] [Abstract][Full Text] [Related]
6. The roles of alpha-vitamin E and its analogues in prostate cancer. Ni J; Yeh S Vitam Horm; 2007; 76():493-518. PubMed ID: 17628187 [TBL] [Abstract][Full Text] [Related]
7. Can prostate cancer be prevented? Klein EA Nat Clin Pract Urol; 2005 Jan; 2(1):24-31. PubMed ID: 16474573 [TBL] [Abstract][Full Text] [Related]
8. Tocopherols and prostate cancer. Cooney RV Hawaii Med J; 2006 Sep; 65(9):268-70. PubMed ID: 17153673 [No Abstract] [Full Text] [Related]
9. Largest-ever prostate cancer prevention trial. FDA Consum; 2001; 35(5):8. PubMed ID: 11697103 [No Abstract] [Full Text] [Related]
10. StatBite: Physicians' Health Study II randomized controlled trial results. J Natl Cancer Inst; 2009 Apr; 101(7):447. PubMed ID: 19318629 [No Abstract] [Full Text] [Related]
11. SELECT (opportunity for prostate cancer prevention). Tom J Hawaii Med J; 2002 Jun; 61(6):126, 129. PubMed ID: 12148409 [No Abstract] [Full Text] [Related]
12. Changes in serum proteomic patterns by presurgical alpha-tocopherol and L-selenomethionine supplementation in prostate cancer. Kim J; Sun P; Lam YW; Troncoso P; Sabichi AL; Babaian RJ; Pisters LL; Pettaway CA; Wood CG; Lippman SM; McDonnell TJ; Lieberman R; Logothetis C; Ho SM Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1697-702. PubMed ID: 16030104 [TBL] [Abstract][Full Text] [Related]
13. [Selenium in complementary oncology. A critical comments on the SELECT trial]. Gröber U Med Monatsschr Pharm; 2010 Apr; 33(4):140-2. PubMed ID: 20429404 [No Abstract] [Full Text] [Related]
14. Update on prostate cancer chemoprevention. Lowe JF; Frazee LA Pharmacotherapy; 2006 Mar; 26(3):353-9. PubMed ID: 16503715 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo anticancer effects of the novel vitamin E ether analogue RRR-alpha-tocopheryloxybutyl sulfonic acid in prostate cancer. Ni J; Mai T; Pang ST; Haque I; Huang K; DiMaggio MA; Xie S; James NS; Kasi D; Chemler SR; Yeh S Clin Cancer Res; 2009 Feb; 15(3):898-906. PubMed ID: 19188160 [TBL] [Abstract][Full Text] [Related]
16. Vitamin E and selenium supplementation and risk of prostate cancer in the Vitamins and lifestyle (VITAL) study cohort. Peters U; Littman AJ; Kristal AR; Patterson RE; Potter JD; White E Cancer Causes Control; 2008 Feb; 19(1):75-87. PubMed ID: 17943452 [TBL] [Abstract][Full Text] [Related]
17. Androgens and prevention of prostate cancer. Sarvis JA; Thompson IM Curr Opin Endocrinol Diabetes Obes; 2008 Jun; 15(3):271-7. PubMed ID: 18438176 [TBL] [Abstract][Full Text] [Related]
18. Vitamin E may reduce prostate-cancer incidence. Bonn D Lancet; 1998 Mar; 351(9107):961. PubMed ID: 9734953 [No Abstract] [Full Text] [Related]
19. Selenium and prostate cancer. Harv Mens Health Watch; 2007 Mar; 11(8):4-6. PubMed ID: 17390473 [No Abstract] [Full Text] [Related]
20. Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway. Ni J; Wen X; Yao J; Chang HC; Yin Y; Zhang M; Xie S; Chen M; Simons B; Chang P; di Sant'Agnese A; Messing EM; Yeh S Cancer Res; 2005 Nov; 65(21):9807-16. PubMed ID: 16267002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]